Article
Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency
13 Sept 2017
Abstract excerpt
Abstract Mismatch repair (MMR)–deficient cancers have been discovered to be highly responsive to immune therapies such as PD-1 checkpoint blockade, making their definition in patients, where they may be relatively rare, paramount for treatment decisions. In this study, we utilized patterns of mutagenesis known as mutational signatures, which are imprints of the mutagenic processes associated with MMR deficiency,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
